EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Immunotherapy and IVF Outcomes in Unexplained Recurrent Pregnancy Loss: A Systematic Review with Implications for Personalized Reproductive Medicine

Giosuè Giordano Incognito iD, Carla Ettore iD, Marco D'Asta, Ferdinando Antonio Gulino, Roberta Foti, Roberto Tozzi iD, Orazio De Tommasi, Pierluigi Chieppa iD, Stefano Di Michele iD, Giuseppe Ettore

Journal of Personalized Medicine · 06.12.2025 · 15 (12) · 606

DOI: 10.3390/jpm15120606 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 06.12.2025. Verfasst von Giosuè Giordano Incognito und 9 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Unit, Maternal Child Department, ARNAS Garibaldi Nesima, 95122 Catania, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Recurrent pregnancy loss (RPL) is one of the most challenging conditions in reproductive medicine, particularly when no identifiable cause can be determined after diagnostic evaluation. Although the role of immunological dysregulation has been hypothesized, the implementation of immunotherapies in clinical practice is controversial due to inconsistent findings and methodological heterogeneity across studies. This systematic review aims to provide an overview of the main characteristics of existing research on the role of immunological interventions in relation to In Vitro Fertilization (IVF) outcomes in women with RPL. Given the marked inter-individual variability in immunological mechanisms among affected women, evaluating these treatments may help identify future directions for personalized reproductive medicine.

Methods

A comprehensive bibliographic search was systematically conducted from inception to October 2025 across databases, including Medline, Embase, Scopus, the Cochrane Database of Systematic Reviews, and ClinicalTrials.gov. Studies were included if they evaluated the efficacy of immunological treatments in women with unexplained RPL, comparing IVF outcomes between case and control groups.

Results

Six cohort studies were included, four retrospective and two prospective. The immunological treatments investigated were granulocyte colony-stimulating factor (G-CSF), intravenous intralipid (with or without prednisolone), and lymphocyte immunization therapy (LIT). Despite some promising results, particularly for G-CSF and LIT, the studies were limited by small sample sizes, heterogeneous diagnostic criteria for RPL, and inconsistent treatment protocols. Furthermore, not all IVF outcomes, such as implantation and biochemical pregnancy rates, were reported.

Conclusions

Current evidence is insufficient to support the use of immunotherapy in clinical practice for improving IVF outcomes in women with unexplained RPL. The variability in study design, patient selection, and immunotherapy regimens hinders the ability to draw firm conclusions. Well-designed randomized controlled trials with standardized definitions and outcome measures are needed to determine whether and for whom immunological treatments may offer clinical benefit.

Schlagwörter

Stichwörter der Autor:innen

assisted reproductive techniqueembryo implantationimmunologyin vitro fertilizationrecurrent pregnancy loss

Autor:innen und Institutionen

  • Obstetrics and Gynecology Unit, Maternal Child Department, ARNAS Garibaldi Nesima, 95122 Catania, Italy.
  • Unit of Gynecology and Obstetrics, Department of Human Pathology of Adults and Developmental Age, "G. Martino" University Hospital, 98125 Messina, Italy.
  • Division of Rheumatology, AOU Policlinico "G. Rodolico"-San Marco, 95123 Catania, Italy.
  • Unit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35128 Padua, Italy.
  • Gynecology and Obstetrics 1, Department of Surgical Sciences, A.O.U. City of Health and Science of Turin, S. Anna Hospital, 10126 Turin, Italy.
  • Division of Obstetrics and Gynecology, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.

ORCID-Profile: Giosuè Giordano Incognito, Carla Ettore, Roberto Tozzi, Pierluigi Chieppa, Stefano Di Michele

Zitieren

APA

Incognito, G. G., Ettore, C., D'Asta, M., Gulino, F. A., Foti, R., Tozzi, R., De Tommasi, O., Chieppa, P., Di Michele, S., & Ettore, G. (2025). Immunotherapy and IVF Outcomes in Unexplained Recurrent Pregnancy Loss: A Systematic Review with Implications for Personalized Reproductive Medicine. Journal of Personalized Medicine, 15(12), 606. https://doi.org/10.3390/jpm15120606

Vancouver

Incognito GG, Ettore C, D'Asta M, Gulino FA, Foti R, Tozzi R, et al. Immunotherapy and IVF Outcomes in Unexplained Recurrent Pregnancy Loss: A Systematic Review with Implications for Personalized Reproductive Medicine. Journal of Personalized Medicine. 2025;15(12):606. doi:10.3390/jpm15120606

BibTeX
@article{Incognito2025,
  author = {Incognito, Giosuè Giordano and Ettore, Carla and D'Asta, Marco and Gulino, Ferdinando Antonio and Foti, Roberta and Tozzi, Roberto and De Tommasi, Orazio and Chieppa, Pierluigi and Di Michele, Stefano and Ettore, Giuseppe},
  title = {Immunotherapy and IVF Outcomes in Unexplained Recurrent Pregnancy Loss: A Systematic Review with Implications for Personalized Reproductive Medicine},
  journal = {Journal of Personalized Medicine},
  year = {2025},
  volume = {15},
  number = {12},
  pages = {606},
  doi = {10.3390/jpm15120606}
}
Kostenlos starten →